Beckley Psytech
VerifiedHelping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines
Launch date
Employees
Ownership
Firm valuation
$306—459m (Dealroom.co estimates Aug 2021.)
Beckley England (HQ)
RELATED LANDSCAPES AND LISTS
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| £3m | Series A | ||
| £14m | Series A | ||
| £58m | Series B | ||
| Total Funding | $99m | ||
Recent News about Beckley Psytech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.